Bank Pictet & Cie (Europe)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.2M | Buy |
733,686
+204,000
| +39% | +$5.63M | 0.43% | 53 |
|
|
2025
Q1 | $15M | Hold |
529,686
| – | – | 0.36% | 57 |
|
|
2024
Q4 | $22M | Hold |
529,686
| – | – | 0.48% | 51 |
|
|
2024
Q3 | $35.4M | Buy |
529,686
+7,060
| +1% | +$472K | 0.84% | 36 |
|
|
2024
Q2 | $62.1M | Sell |
522,626
-1,000
| -0.2% | -$119K | 1.51% | 18 |
|
|
2024
Q1 | $55.8M | Hold |
523,626
| – | – | 1.45% | 23 |
|
|
2023
Q4 | $52.1M | Buy |
523,626
+29,338
| +6% | +$2.92M | 1.54% | 20 |
|
|
2023
Q3 | $51.1M | Buy |
494,288
+150,000
| +44% | +$15.5M | 1.78% | 17 |
|
|
2023
Q2 | $41.8M | Buy |
344,288
+1,124
| +0.3% | +$137K | 1.42% | 23 |
|
|
2023
Q1 | $52.7M | Buy |
343,164
+197,928
| +136% | +$30.4M | 2.19% | 12 |
|
|
2022
Q4 | $26.1M | Buy |
145,236
+102,947
| +243% | +$18.5M | 1.28% | 22 |
|
|
2022
Q3 | $5M | Buy |
42,289
+37,546
| +792% | +$4.44M | 0.25% | 66 |
|
|
2022
Q2 | $678K | Hold |
4,743
| – | – | 0.03% | 111 |
|
|
2022
Q1 | $817K | Sell |
4,743
-1,454
| -23% | -$250K | 0.03% | 108 |
|
|
2021
Q4 | $1.57M | Buy |
6,197
+3,343
| +117% | +$849K | 0.05% | 94 |
|
|
2021
Q3 | $1.1M | Sell |
2,854
-181
| -6% | -$69.6K | 0.04% | 102 |
|
|
2021
Q2 | $713K | Buy |
3,035
+215
| +8% | +$50.5K | 0.02% | 116 |
|
|
2021
Q1 | $369K | Buy |
+2,820
| New | +$369K | 0.01% | 140 |
|